TranspareRx will soon launch Cuverd – The Next-Generation Prescription Savings Platform and App
NAPLES, Fla. – …
Author: Eric Jones
Recora and Tampa General Hospital Heart & Vascular Institute Partner to Offer New Cardiac Recovery Program to Thousands
The partnership will bring medically supported virtual cardiac rehabilitation and recovery into the homes of patients in Tampa General’s 23-county service area
NEW YORK & TAMPA, Fla. – September 8, 2022 – (Newswire.com)
Recora today announced that it is partnering with the Tampa General Hospital Heart & Vascular Institute for its Cardiac Recovery Program. This program will be the first of its kind in Florida’s Tampa Bay region, expanding Tampa General Hospital’s (TGH) outpatient cardiac rehabilitation program to more eligible patients in the academic medical center’s 23-county service area.
“Cardiac rehabilitation with supervised, escalating doses of exercise is crucial for complete recovery from a major cardiovascular surgery or procedure. Similarly, patients with heart failure can receive enormous benefit from cardiac rehabilitation. The main barrier for patients to fully benefit from this therapy has always been convenience and access,” said Dr. Guilherme Oliveira, professor and chief, Division of Cardiovascular Sciences, USF Health Morsani College of Medicine, and executive director, Tampa General Heart & Vascular Institute. “Recora removes the access barrier and provides the convenience that patients need to successfully complete cardiac recovery and rehabilitation by allowing this to happen right at home. It’s a game changer for patients that require cardiac rehabilitation.”
Through virtual tools provided to patients and on-demand access to care teams and other resources, the program empowers patients to manage their heart health from home while enabling providers and plans to provide comprehensive cardiac care and strengthen patient relationships. Recora currently serves more than 30,000 cardiac patients in the U.S. across health systems, health plans and medical groups in urban, suburban and rural communities.
Recora’s Cardiac Recovery Program moves beyond 12 weeks of rehabilitation to deliver comprehensive care management that focuses on a patient’s overall health and wellness.
“Today, one in four people in the U.S. die of heart disease, according to the Centers for Disease Control and Prevention (CDC). Although cardiac rehabilitation is considered the standard of care, just 16% of eligible patients start the program and 26% finish all sessions. Tampa General has made the decision to change that,” said Recora CEO Abhishek Chandra. “We are excited to extend Tampa General’s care delivery to patients within their own home through a personalized and convenient cardiac rehabilitation curriculum that can engage patients in continuing a healthier lifestyle that can improve their health.”
Recora’s Cardiac Recovery Program has already garnered industry-leading results that include:
- 15% hospital readmission rate for Recora patients, versus the national average of 43% across Medicare patients with heart failure at six months.
- 87% Recora cardiac recovery program completion rate, versus the national average of 26%.
- 95% of Recora patients with hypertension improved into normal blood pressure ranges.
- 94% of Recora patients adhere to their cardiac medication.
- 80% improvement of distance and strength gains among Recora patients.
In addition to its strategic collaboration with Recora, Tampa General participated in Recora’s most recent Series A round of financing, which was led by San Francisco-based venture capital firm SignalFire. The Series A funding will help accelerate Recora’s product and technology development, as well as grow its sales and marketing efforts, according to the company.
Tampa General’s participation was coordinated through TGH Innoventures, which, among other things, provides Tampa General with a platform to invest resources and funds into emerging companies. “We are very excited to expand our partnership with Recora by making this strategic investment,” said Rachel Feinman, vice president of Innovation at TGH and managing director of TGH Innoventures. “This investment emphasizes our commitment to driving growth and providing value to companies we believe have the potential to transform the future of healthcare.”
ABOUT RECORA
Recora’s mission is to redefine the future of heart health. Recora’s Cardiac Recovery Program for health systems, medical groups and health plans makes it easier to recover from a cardiac event through immersive programs delivered online. With Recora, health care providers are able to establish a longitudinal relationship with patients and help them live longer, fuller lives. To learn more, visit recora.com.
ABOUT TAMPA GENERAL HOSPITAL
Tampa General Hospital, a 1,040-bed, not-for-profit, academic medical center, is one of the largest hospitals in America and delivers world-class care as the region’s only center for Level l trauma and comprehensive burn care. Tampa General Hospital is the highest-ranked hospital in the market in U.S. News & World Report’s 2022-23 Best Hospitals, and is tied as the third highest-ranked hospital in Florida, with seven specialties ranking among the best programs in the United States. Tampa General Hospital has been designated as a model of excellence by the 2022 Fortune/Merative 100 Top Hospitals list. The academic medical center’s commitment to growing and developing its team members is recognized by two prestigious Forbes magazine rankings — first nationally in the 2022 America’s Best Employers for Women and third out of 100 Florida companies in the 2021 America’s Best Employers by State. Tampa General is the safety net hospital for the region, caring for everyone regardless of their ability to pay, and in fiscal year 2020, provided a net community benefit worth more than $182.5 million in the form of health care for underinsured patients, community education, and financial support to community health organizations in Tampa Bay. It is one of the nation’s busiest adult solid organ transplant centers and is the primary teaching hospital for the USF Health Morsani College of Medicine. With six medical helicopters, Tampa General Hospital transports critically injured or ill patients from 23 surrounding counties to receive the advanced care they need. Tampa General houses a nationally accredited comprehensive stroke center, and its 32-bed Neuroscience, Intensive Care Unit is the largest on the West Coast of Florida. It also is home to the Jennifer Leigh Muma 82-bed Level IV neonatal intensive care unit, and a nationally accredited rehabilitation center. Tampa General Hospital’s footprint includes 17 Tampa General Medical Group Primary Care offices, TGH Family Care Center Kennedy, TGH Brandon Healthplex, TGH Virtual Health, and 21 TGH Imaging powered by Tower outpatient radiology centers throughout Hillsborough, Pasco, Pinellas and Palm Beach counties. Tampa Bay area residents also receive world-class care from the TGH Urgent Care powered by Fast Track network of clinics, and they can even receive home visits in select areas through TGH Urgent Care at Home, powered by Fast Track. As one of the largest hospitals in the country, Tampa General Hospital is the first in Florida to partner with GE Healthcare and open a clinical command center that provides real-time situational awareness to improve and better coordinate patient care at a lower cost. For more information, go to www.tgh.org.
Media Contacts:
Adam Hritzak
Director of Marketing, Recora
(614) 946-7916 | [email protected]
Karen Barrera
Assistant Director Communications & Partnerships
(813) 928-1603 | [email protected]
Press Release Service
by
Newswire.com
Original Source:
Recora and Tampa General Hospital Heart & Vascular Institute Partner to Offer New Cardiac Recovery Program to Thousands
Rebel Wilson on weight loss, health and fertility – BBC News
Rebel Wilson shot to fame as one of Hollywood’s top comedy actresses after appearing in the 2011 box-office hit Bridesmaids and the Pitch Perfect franchise. In an exclusive interview, Rebel reflects on her decision to lose weight during her “year of health”, what it means to be the “funny fat girl” in Hollywood, and her […]
Investigational 2.0mg Semaglutide Dose Promoted for Type 2 Diabetics With Higher A1c Score
Ozempics Continuing to Stand Out as a New Type 2 Diabetes Medication Alternative
Canadian pharmacy logo Canadian pharmacy
VICT…
Maria Toler Velissaris Awarded 2022 Eisenhower Fellowship
Maria Toler Velissaris, Founding Partner of SteelSky Ventures, was selected for the prestigious Eisenhower Fellowship where she will travel to Rwanda and Spain to progress the state of maternal healthcare
…
Iodine Software Teams With TruCode to Help Health Systems Capture More Earned Revenue
Iodine Software’s 2022 Best in KLAS solution integrates with TruCode Encoder Essentials software to drive more efficient and accurate clinical documentation improvement.
AUSTIN, Texas – September 7, 2022 – (Newswire.com)
Iodine Software, the leading enterprise AI software in healthcare, and TruCode, a CPSI company that provides encoder technology solutions that maximize coding efficiency, today announced a partnership that enables health systems and hospitals to more effectively perform clinical documentation improvement (CDI).
Iodine Software will integrate TruCode Encoder Essentials directly into its AwareCDI suite. The combined solutions will provide CDI teams with easy access to detailed diagnosis and procedure code reference information directly in their workflows, in addition to access to complete official code books.
“Clinical documentation improvement is one of the most important areas of hospital operations and has a direct impact on both revenue performance and clinical quality. However, it often requires healthcare professionals to complete complex and tedious work that can negatively impact organizational performance. We want our clients’ CDI teams to have the best tools and resources available to them to streamline their work, minimize stress and create a positive working environment,” said William Chan, Iodine Software Co-founder and CEO. “Providing TruCode’s industry-leading technology within our AwareCDI Suite will allow CDI professionals to have the confidence that every claim has a complete and accurate reflection of the patient encounter, ultimately supporting earned-revenue opportunities and reducing denials.”
AwareCDI is based on Iodine Software’s proprietary CognitiveML technology, the most advanced and versatile AI engine available in healthcare. It’s the only available market solution that addresses mid-cycle revenue cycle leakage at each step, which is one reason why it was recently named the 2022 Best In KLAS CDI Software by KLAS Research with a score of 91.2.
By embedding TruCode’s robust coding resources directly into AwareCDI, CDI teams can easily access resources that support accurate capture of documentation and code assignment resulting in appropriate claim reimbursement and accurate reporting of patient outcomes.
“This partnership offers tremendous opportunity for hospitals and health systems because it brings together two industry-leading technologies, each with proven success. By combining TruCode’s expertise in encoder technology and coding workflows with Iodine’s powerful AI engine, we can deliver real value for healthcare organizations looking to improve the quality of care they deliver while improving revenue capture,” said Chris Fowler, CPSI CEO.
An estimated 84 percent of healthcare leaders believe that a root cause of lost or decreased revenue is inaccurate clinical documentation and coding, which can cost the average hospital $5-10M for the average 250-bed hospital in revenue leakage. By integrating AI and coding software directly into a CDI team’s workflow, provider organizations can capture earned revenue and minimize physician burnout caused by documentation and coding processes.
About Iodine Software
Iodine is an enterprise AI company that is championing a radical rethink of how to create value for healthcare professionals, leaders, and their organizations: automating complex clinical tasks, generating insights and empowering intelligent care. Iodine’s powerful predictive engine complements the skills and judgment of healthcare professionals by interpreting raw clinical data to generate real-time, highly focused, predictive insights that clinicians and hospital administrators can leverage to dramatically augment the management of care delivery – facilitating critical decisions, scaling clinical workforces through automation, and improving the financial position of health systems. For more information, please visit iodinesoftware.com.
About TruCode
TruCode offers innovative medical coding software solutions to the hospital, consulting, and healthcare IT markets. Since 2005, TruCode’s team of passionate and experienced health information professionals has been dedicated to developing the most intuitive encoder available.
The release of the Encoder Essentials in 2011—a set of web services and components that allow TruCode’s encoder technology to be embedded within other software platforms—took TruCode to new heights. Industry-leading Computer Assisted Coding (CAC), Clinical Documentation Improvement (CDI), and auditing solutions providers have partnered with TruCode to incorporate their encoder functionality into their own software.
In 2021, CPSI saw the value of bringing leading coding technology to their TruBridge business and acquired TruCode. As part of TruBridge, TruCode’s solutions have helped to enhance TruBridge’s patient management and revenue cycle solutions, helping them more effectively clear the way for care.
PR Contact:
[email protected]
Press Release Service
by
Newswire.com
Original Source:
Iodine Software Teams With TruCode to Help Health Systems Capture More Earned Revenue
Concordance Names Clinton ‘Lee’ Holmes as Chief Administrative Officer
ST. LOUIS – September 7, 2022 – (Newswire.com)
Concordance, a CARF accredited, non-profit re-entry program headquartered in St. Louis, announced today that Clinton “Lee” Holmes has joined Concordance as Chief Administrative Officer. He will report to Danny Ludeman, Concordance Chairman & CEO.
In his role at Concordance, Mr. Holmes will be responsible for executing administrative oversight for several departments across the organization including finance, human resources, information technology, and facilities. He will also oversee the implementation of organizational policies across administrative and participant service departments.
“Having worked as an employment partner with Concordance for two and a half years, I got to see first-hand how they impacted the lives of justice-involved individuals and personally experience the passion and caring their team members exhibited while interacting with Concordance participants,” said Mr. Holmes. “This experience has impacted me significantly, to such a degree that I am proud to have joined this inspiring organization and work alongside the Concordance team members and participants that I have gotten to know!”
Mr. Holmes joins Concordance from Triad Manufacturing, having served as their Human Resources Manager. As Human Resources Manager, he led all aspects of human resources, including benefits, recruiting, training, strategy management, worker’s compensation, 401K, and the Employee Stock Ownership Plan (ESOP). He also served on Concordance’s Employer Advisory Council where he provided valuable insight on trends in the talent market and how they could impact the Concordance Employment Agency. Before joining Triad Manufacturing, Mr. Holmes was the Chief Operating Officer of NVision IT where he managed navigating business relationships within the government contracting sector.
“Through Concordance’s partnership with Triad Manufacturing as a hiring partner and by serving on the Concordance Employer Advisory Council, Lee’s passion for our mission and the well-being of our participants was obvious,” said Ludeman. “As Chief Administrative Officer, Lee’s role will be critical to our organization as we expand the Concordance Re-Entry Model nationally to 11 new cities in the next five years. And I am honored that he is joining us on this journey.”
With over 20 years of experience in HR, Finance, and IT, Mr. Holmes has vast expertise in financial reporting, banking relations, corporate and legal oversight, risk mitigation, employee relations, safety management, recruiting, benefits, regulatory compliance, and business development. Mr. Holmes is a retired Major with the United States Army Reserve and earned his Bachelor of Arts in Business Administration, with an Accounting minor, from McDaniel College in Westminster, Maryland.
About Concordance
Concordance is a CARF-accredited nonprofit that offers holistic, and evidence-informed services to individuals returning to their community from prison. Founded in 2015 by Danny Ludeman, former CEO of Wells Fargo Advisors, Concordance has lowered the rate of reincarceration by 56 percent among its participants who have released from prison in the last three years. The nonprofit works with individuals in three primary areas: behavioral health and wellness; education and employment; and community and life skills. Concordance is committed to healing individuals, reuniting families, transforming communities, achieving racial equity, and advancing the field of re-entry services. Headquartered in St. Louis, Concordance is working toward national expansion, with plans to bring its re-entry model to 11 additional cities nationwide over the next five years. For more information, visit https://concordance.org. Resources for news media including fact sheets, photos, and videos are available at https://concordance.org/media-kit.
CONCORDANCE MEDIA CONTACTS
Jill Lewin – 314-396-6024
[email protected]
Sivan Fernandez – 314-396-6045
[email protected]
Press Release Service
by
Newswire.com
Original Source:
Concordance Names Clinton ‘Lee’ Holmes as Chief Administrative Officer
Overwhelmed Mental Health Care Workers Demonstrate Need for New Ways to Provide Care
ADHD Online alleviates overburdened system’s long wait times for patients to receive ADHD assessments, treatments, and care
GRAND RAPIDS, Mich. – September 7, 2022 – (Newswire.com)
An ongoing strike by mental health workers, coupled with state laws that mandate urgent responses to mental health issues, highlight the need for expanded resources for mental health care such as the assessment, diagnosis and treatment services provided by ADHD Online.
Recent events in California highlight a looming national problem. A new state law, passed in 2021, mandates that mental health providers respond quickly to requests for mental health care – including offering appointments within 10 business days. Psychologists, therapists and other mental health professionals say they are stretched too thinly, prompting the strike.
Those resource constraints force routine procedures like ADHD assessments to be treated as low priority, creating months-long wait times for assessments. Strikes by mental health push out ADHD assessment appointments even further, past 12 months in most cases, according to ADHD Online. And that places tremendous stress on individuals and families.
“Because ADHD assessments are not considered urgent, a family member may be waiting far too long to get answers and start living a better life,” said Zachariah Booker, CEO and co-founder of ADHD Online. “If you’ve had that experience, you know that you can’t get answers quickly enough.”
ADHD Online, founded in 2018, alleviates the burden on traditional mental health services through its system of HIPAA-secured, online ADHD assessments that connect people with licensed, doctoral-level psychologists who can perform ADHD assessments within three to five days.
ADHD Online’s certified assessments and any resulting diagnoses can be taken to patients’ own primary care providers for treatment, or the patient can use ADHD Online’s network of providers for ongoing treatment. In select states, ADHD Online also offers streamlined teletherapy appointments with master-level clinicians over HIPAA-compliant Zoom accounts.
“We know that the mental health care system is overburdened and that people need better ways to get the care they need,” Booker said. “Our mission is to ensure that everyone should have access to quality ADHD assessments regardless of who and where they are, and we have built a team of licensed professionals who are passionate about providing that care.”
ADHD Online is the only organization to offer HIPAA-secured ADHD assessments online with certified results from licensed psychologists. After diagnosis, ADHD Online providers and patients develop an ADHD treatment plan which may include medication and therapy, but the company does not advocate for treating all patients with medication and has no relationships with pharmaceutical companies.
For any patients beginning medication, ADHD Online requires an initial 30-day follow-up visit and repeated 90-day follow-ups if the patient is stable on their medications. Patients also provide their vital signs to ADHD Online throughout their care.
Please visit https://adhdonline.com for more information.
About ADHD Online
ADHD Online was founded in 2018 with the mission that everyone should have access to quality ADHD assessments regardless of who and where they are. The ADHD Online team is filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services. ADHD Online is leading the way with being a critical voice for those who might be struggling with ADHD and is the only organization to offer HIPAA-secured ADHD assessments online with certified results from licensed psychologists. ADHD Online is active in all 50 states.
Media Contact
Dan Johnson
[email protected]
Press Release Service
by
Newswire.com
Original Source:
Overwhelmed Mental Health Care Workers Demonstrate Need for New Ways to Provide Care
The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH
The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) enter a strategic partnership to use artificial intelligence (AI) powered tool for the diagnosis and staging of NASH (non-Alcoholic Steatohepatitis) in patients with type 2 diabetes (T2D).
FibroNest’s AI scores Fibrosis Severity in Liver Biopsies
Liver Biopsies in three different stages of fibrosis severity are automatically scored by Fibronest with reproducibility and detection thresholds that exceed current methods
PARIS – September 7, 2022 – (Newswire.com)
The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) announced today that they have entered a strategic partnership that will support the development and validation of a virtual liver biopsy (non-invasive) and artificial intelligence (AI)-powered tool for the diagnosis and staging of NASH (Non-Alcoholic Steatohepatitis) in patients with type 2 diabetes (T2D).
The clinical study involves 600 type 2 diabetic patients who are receiving a liver biopsy as part of standard care. The data collected (imaging, deep clinico-biological phenotyping, different omic approaches, extracellular vesicles and immune blood cell profiling) will be analyzed with the Swiss Institute of Bioinformatics (SIB) and Bichat biostatistical teams through comprehensive and deep bioinformatics and biostatistics.
Through its cloud-based, Digital Pathology platform FibroNest, PharmaNest will generate single-fiber and single-nuclei high-content quantitative histological datasets from each digital biopsy image to generate continuous scores that quantify the phenotypes of fibrosis and stage the severity of fibrosis and disease activity of NASH. This dataset will enrich the data collected and enable the consortium to discover novel histological phenotypes of NASH in T2D patients.
“The quantitative FibroNest method resolves the limitation of the current categorical and semi-quantitative methods and paradigms used of the histological assessment of liver biopsies,” says Prof. Valerie Paradis, Chair of the Pathology Department at Beaujon Hospital and leader of the INSERM team.
“PharmaNest is excited to enable the QUID NASH consortium to enter the research field of Pathomic-Fusion and provide a robust and automated method for the quantification of the fibrosis,” says Mathieu Petitjean, Ph.D., CEO of PharmaNest, Inc.
“The addition of FibroNest’s Digital Pathology and Artificial intelligence capabilities to the QUID-NASH consortium will enhance performance of our upcoming virtual biopsy tests and generate significant upside for the investigation and understanding of NASH in T2D patients,” says Pr. Dominique Valla, Principal Investigator and founding director of the French Reference Center for Vascular Diseases of the Liver
About QUID-NASH
The QUID-NASH research program is a clinical research consortium that includes Assistance Publique-Hôpitaux de Paris, Universities Paris-Descartes and Paris-Diderot, Commissariat à l’Energie Atomique (CEA), Laboratoires Servier and BioPredictive which operate under the leadership of the National Institute of Health and Medical Research (INSERM) of France. Clinical sites and teams include diabetology in Lariboisière and Cochin hospitals, Hepatology in Beaujon and Cochin, Imaging in Necker Beaujon and Physics for Medecine Paris.
About PharmaNest
PharmaNest is a Digital Pathology and Artificial Intelligence company focused on the development and validation of novel histological standards for the quantification of Inflammation and fibrosis. Its multivendor platform, FibroNest, is delivered worldwide via the cloud and used in multiple pre-clinical and clinical studies across several fibrotic conditions.
For more information about FibroNest and PharmaNest, visit www.pharmanest.com and www.fibronest.com
Media Contact
Mathieu M. Petitjean, Ph.D.
CEO, PharmaNest
Press Release Service
by
Newswire.com
Original Source:
The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH